Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Aug 1, 2025
Open Peer Review Period: Aug 4, 2025 - Sep 29, 2025
Date Accepted: Jan 16, 2026
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Understanding Responsible Development in AI-Based Clinical Prediction Models for Mortality: Protocol for a Scoping Review

Martens R, Holodinsky JK, Simon J, Marshall Z

Understanding Responsible Development in AI-Based Clinical Prediction Models for Mortality: Protocol for a Scoping Review

JMIR Res Protoc 2026;15:e80325

DOI: 10.2196/80325

Understanding Responsible Development in Artificial Intelligence-based Clinical Prediction Models (AIPM) that Prognosticate Mortality: A Scoping Review Protocol

  • Riley Martens; 
  • Jessalyn Kathryn Holodinsky; 
  • Jessica Simon; 
  • Zack Marshall

ABSTRACT

Background:

Prognostic inequity has been identified as a barrier to accessing end-of-life care for underrepresented groups. Artificial Intelligence using Clinical Prediction Models (AIPMs) prognosticating mortality have the potential to offer rapid, accessible, and accurate predictions that could streamline care. However, they may also exacerbate pre-existing inequities in the healthcare system, rather than addressing accessibility and quality. This can include erroneous outputs from biased training data, outcomes from out-of-scope operationalization, and inexplicability due to opacity.

Objective:

The goal of this study is to synthesize peer-reviewed literature on the creation and application of clinical prediction models using artificial intelligence to prognosticate mortality in acute care settings for adult patients, offering new insights into responsible and ethical model development.

Methods:

A transdisciplinary, structured search strategy was developed in consultation with librarians from both health sciences and engineering sciences. The academic databases queried were Medline, Embase, IEEE Xplore, ACM Digital Library, Compendex, and Scopus. The search was conducted in Spring 2025, and the results were uploaded to Covidence. A team of reviewers will screen in two rounds: title-abstract, then full-text. Eligibility will be determined by publication in academic journals or as full-length conference proceedings, language, model output, and AI use. Data will be charted using adapted charting tools and then analysed by descriptive summary and qualitative synthesis.

Results:

The search was completed on March 25, 2025, with screening starting in May 2025. Results are anticipated for January 2026.

Conclusions:

This review will provide a comprehensive summary of AI clinical prediction models that output mortality, highlighting the specific elements included in their development. Informed by the Responsible Research and Innovation framework, this study will identify relevant elements, including interest holder engagement, interdisciplinary collaboration, and computational and clinical ethics, regarding AIPMs. These aspects will be relevant to understanding the responsible development of tools designed for mortality prediction in relation to anticipation, reflexivity, inclusion, and responsiveness.


 Citation

Please cite as:

Martens R, Holodinsky JK, Simon J, Marshall Z

Understanding Responsible Development in AI-Based Clinical Prediction Models for Mortality: Protocol for a Scoping Review

JMIR Res Protoc 2026;15:e80325

DOI: 10.2196/80325

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.